About Leveragen
Leveragen is a Healthcare company based in Cambridge (United States) founded in 2017 by Weisheng V Chen. Customized genetic engineering services are provided using CRISPR technology. Leveragen offers products and services including Genetic Engineering Platform and Antibody Discovery Platform. Its focus areas include Life Sciences, Genomics, Genomics Services and Genome Engineering. Its legal entity is Leveragen, Inc. Its competitors include Rejuvenate Bio, Strateos and Genewiz; 2 of its 3 listed competitors have raised funding.
Company details
Leveragen was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where customized genetic modeling services are delivered through CRISPR-facilitated gene targeting in embryonic stem cells. Mutations are screened in these cells prior to knockout mouse development, enabling large fragment knockins and complex genetic modifications for research applications.
- Headquarters Cambridge, United States
- Founders Weisheng V Chen
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website leveragen.com
- Social LinkedIn X
- Legal Name Leveragen, Inc.
Products & Services of Leveragen
Leveragen offers a comprehensive portfolio of products and services, including Genetic Engineering Platform and Antibody Discovery Platform.
Platform for genome editing and biotherapeutics development using CRISPR
System for identifying and engineering antibodies via phage display
People of Leveragen
8 people are tracked at Leveragen (5 in leadership, 3 in team).
| Name | Role | Group |
|---|---|---|
Weisheng V Chen | Founder | Leadership |
Brian O'Nuallain | Director, Head Of In Vitro Discovery And External Innovation | Leadership |
Hugh Cam | Director of Research | Leadership |
Weisheng Chen | Founder and CEO | Leadership |
Samantha Meske | Executive Assistant To Chief Executive Officer | Leadership |
Shi Lei | Principal Scientist at Leveragen | Team |
Chia-Ching C. | Principal Scientist | Team |
PENG DING | Principle Research Associate | Team |
Complete people profiles for Leveragen
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Competitors of Leveragen
Leveragen has 3 listed competitors in our database, 2 of them funded. They include Rejuvenate Bio, Strateos and Genewiz.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rejuvenatebio.com | 2017 | San Diego, United States | $14.58M | 39 | Gene-editing platform and anti-aging therapy for dogs are developed. | |
| strateos.com | 2019 | Menlo Park, United States | $72.6M | 147 | Provider of cloud based platform provides data driven information for biotech research | |
| genewiz.com | 1999 | South Plainfield, United States | 452 | Genomic services are provided for the life sciences industry. |
Detailed competitors of Leveragen
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as Leveragen (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Leveragen
Complete news archive for Leveragen
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Leveragen
Leveragen was founded in 2017.
Leveragen is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Leveragen was founded in 2017 and is based in Cambridge, United States. Operations focus on the biotechnology sector, where customized genetic modeling services are delivered through CRISPR-facilitated gene targeting in embryonic stem cells. Mutations are screened in these cells prior to knockout mouse development, enabling large fragment knockins and complex genetic modifications for research applications.
Leveragen's top competitors include Genewiz, Rejuvenate Bio and Strateos.
Leveragen offers Genetic Engineering Platform and Antibody Discovery Platform.
Leveragen operates through Leveragen, Inc..